A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.
There are 60 items
TCR Sequencing to Identify Responders in Patients with Stage III NSCLC Treated with Atezoluzimab with Chemoradiation (AFT-16).